124 related articles for article (PubMed ID: 23054342)
21. Treatment of neuromyelitis optica and neuromyelitis optica spectrum disorders with rituximab using a maintenance treatment regimen and close CD19 B cell monitoring. A six-year follow-up.
Evangelopoulos ME; Andreadou E; Koutsis G; Koutoulidis V; Anagnostouli M; Katsika P; Evangelopoulos DS; Evdokimidis I; Kilidireas C
J Neurol Sci; 2017 Jan; 372():92-96. PubMed ID: 28017256
[TBL] [Abstract][Full Text] [Related]
22. Anesthetic management of a parturient with neuromyelitis optica.
Sadana N; Houtchens M; Farber MK
Int J Obstet Anesth; 2012 Oct; 21(4):371-5. PubMed ID: 22922089
[TBL] [Abstract][Full Text] [Related]
23. Hiccups as Herald: Neuromyelitis Optica Spectrum Disorder.
Puri A; Chesser M; Chan K; Kharidi V
Am J Med; 2017 Sep; 130(9):1055-1058. PubMed ID: 28599993
[No Abstract] [Full Text] [Related]
24. Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab.
Pellkofer HL; Suessmair C; Schulze A; Hohlfeld R; Kuempfel T
Mult Scler; 2009 Aug; 15(8):1006-8. PubMed ID: 19667025
[TBL] [Abstract][Full Text] [Related]
25. Immunosuppressive therapy is more effective than interferon in neuromyelitis optica.
Papeix C; Vidal JS; de Seze J; Pierrot-Deseilligny C; Tourbah A; Stankoff B; Lebrun C; Moreau T; Vermersch P; Fontaine B; Lyon-Caen O; Gout O
Mult Scler; 2007 Mar; 13(2):256-9. PubMed ID: 17439893
[TBL] [Abstract][Full Text] [Related]
26. [Neuromyelitis optica with atypical cerebral lesions demonstrated by magnetic resonance imaging in a 9-year old girl].
Trautner S; Pedersen H; Bendtson I
Ugeskr Laeger; 2009 Jan; 171(5):334-6. PubMed ID: 19176174
[TBL] [Abstract][Full Text] [Related]
27. What's new in neuromyelitis optica? A short review for the clinical neurologist.
Whittam D; Wilson M; Hamid S; Keir G; Bhojak M; Jacob A
J Neurol; 2017 Nov; 264(11):2330-2344. PubMed ID: 28289845
[TBL] [Abstract][Full Text] [Related]
28. Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
He D; Yu Y; Yan W; Dai Q; Xu Z; Chu L
Pediatr Neurol; 2014 Aug; 51(2):255-8. PubMed ID: 25079575
[TBL] [Abstract][Full Text] [Related]
29. Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Thulasirajah S; Pohl D; Davila-Acosta J; Venkateswaran S
Neuropediatrics; 2016 Aug; 47(4):245-52. PubMed ID: 27128728
[TBL] [Abstract][Full Text] [Related]
30. [Neuromyelitis optica].
Kvistad SA; Wergeland S; Torkildsen Ø; Myhr KM; Vedeler CA
Tidsskr Nor Laegeforen; 2013 Oct; 133(19):2057-61. PubMed ID: 24129537
[TBL] [Abstract][Full Text] [Related]
31. [Neuromyelitis optica in children. Two case reports].
Tosello B; Halbert C; Mancini J; Chabrol B; Boucraut J; Milh M
Arch Pediatr; 2012 Aug; 19(8):827-31. PubMed ID: 22789744
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial.
Nikoo Z; Badihian S; Shaygannejad V; Asgari N; Ashtari F
J Neurol; 2017 Sep; 264(9):2003-2009. PubMed ID: 28831548
[TBL] [Abstract][Full Text] [Related]
33. A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica.
Mangat P; Ravindran J; Cleland L; Limaye V
Clin Rheumatol; 2008 Dec; 27 Suppl 2():S67-9. PubMed ID: 18560921
[TBL] [Abstract][Full Text] [Related]
34. Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus.
Hernando Rubio I; Belzunegui Otano J; Máiz Alonso O; Alvarez Rodríguez B
Reumatol Clin; 2012; 8(5):298-9. PubMed ID: 22595662
[No Abstract] [Full Text] [Related]
35. Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding.
Kim JS; Cheon S; Kim SW; Kim B; Kim H; Park KD; Kim SM
Biochem Biophys Res Commun; 2016 Sep; 478(2):553-8. PubMed ID: 27462020
[TBL] [Abstract][Full Text] [Related]
36. Neuromyelitis optica immunoglobulin G in a child.
Hudson LA; Bernard TJ; Tseng BS; Miller BR; Corboy JR
Pediatr Neurol; 2006 Nov; 35(5):370-2. PubMed ID: 17074612
[TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis optica spectrum disorder complicated with Sjogren syndrome successfully treated with tocilizumab: A case report.
Komai T; Shoda H; Yamaguchi K; Sakurai K; Shibuya M; Kubo K; Takahashi T; Fujio K; Yamamoto K
Mod Rheumatol; 2016; 26(2):294-6. PubMed ID: 24313919
[TBL] [Abstract][Full Text] [Related]
38. Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica.
Berger JR; Neltner J; Smith C; Cambi F
Mult Scler Relat Disord; 2014 Nov; 3(6):728-31. PubMed ID: 25891552
[TBL] [Abstract][Full Text] [Related]
39. A Case Report on Juvenile Neuromyelitis Optica: Early Onset, Long Remission Period, and Atypical Treatment Response.
Elpers C; Gross CC; Fiedler B; Meuth SG; Kurlemann G
Neuropediatrics; 2015 Aug; 46(4):292-5. PubMed ID: 26058738
[TBL] [Abstract][Full Text] [Related]
40. Favorable outcome of granulocyte colony-stimulating factor use in neuromyelitis optica patients presenting with agranulocytosis in the setting of rituximab.
Mealy MA; Levy M
J Neuroimmunol; 2015 Oct; 287():29-30. PubMed ID: 26439958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
